Miquel Vila Bover I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR) Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Email Miquel Vila Bover Email Instituciones de las que forman parte Jefe de grupo Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)
I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder. In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN). I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.
Proyectos Molecular mechanisms of neurodegeneration: targeting programmed cell death as a new therapeutic strategy for Parkinson's disease IP: - Colaboradores: Miquel Vila Bover Entidad financiadora: EUROPEAN COMMISSION Financiación: Referencia: MIRG-CT-2004-006505 Duración: 31/12/2005 - 30/09/2007 Muerte celular programada como diana terapéutica en la enfermedad de Parkinson IP: Miquel Vila Bover Colaboradores: Laia Perez Lasarte Entidad financiadora: Ministerio de Ciencia e Innovación-MICINN Financiación: 180400 Referencia: RYC-2005-1561 Duración: 12/07/2006 - 31/10/2011 Targeting programmed cell death in Paarkinson's disease (Targeting PCD in PD) IP: - Colaboradores: Miquel Vila Bover Entidad financiadora: EUROPEAN COMMISSION Financiación: Referencia: MEXT-CT-2005-024929 Duración: 01/12/2005 - 30/11/2009 Targetting programmed cell death in Parkinson's disease (Targeting PCD in PD) Grant Agreement No 024929 Contract MEXC-CT-2005-024929 Marie Curie Excellence Grants IP: Miquel Vila Bover Colaboradores: Jordi Bove Badell Entidad financiadora: EUROPEAN COMMISSION Financiación: 1151774.03 Referencia: FP6-PEOPLE-PCD-IN-PD-24929 Duración: 01/12/2005 - 01/12/2009 Paginación Primera página « Página anterior ‹ … Página 6 Página 7 Página 8 Página 9 Página actual 10
